Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

359
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
359
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

996
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
996
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

438
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
438
Distributions to Estimate Population Parameter01:26

Distributions to Estimate Population Parameter

4.5K
The accurate values of population parameters such as population proportion, population mean, and population standard deviation (or variance) are usually unknown. These are fixed values that can only be estimated from the data collected from the samples. The estimates of each of these parameters are sample proportion, the sample mean, and sample standard deviation (or variance). To obtain the values of these sample statistics, data are required that have particular distribution and central...
4.5K
Population Growth00:57

Population Growth

23.2K
Population size is dynamic, increasing with birth rates and immigration, and decreasing with death rates and emigration. In ideal conditions with unlimited resources, populations can increase exponentially, which plots as a J-shaped growth rate curve of population size against time. This type of curve is characteristic of newly-introduced invasive species, or populations that have suffered catastrophic declines and are rebounding.
23.2K
Modeling with Differential Equations01:25

Modeling with Differential Equations

334
Population dynamics can be described mathematically by considering the population size P(t) as a function of time. The rate of change of the population is then represented by the derivative of P(t). A simple assumption is that the rate of growth is proportional to the size of the population itself. This leads to an exponential growth model, where the population increases rapidly without bound. While this is a useful first approximation, it does not reflect realistic long-term...
334

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bridging the blood-brain barrier: strategies to improve delivery of biologics to tumors in the brain.

Fluids and barriers of the CNS·2026
Same author

Population Pharmacokinetics and Exposure-Response Model-Based Bayesian Extrapolation of FVC-Based Efficacy Endpoints From Adults to Pediatric Patients Receiving Nintedanib.

CPT: pharmacometrics & systems pharmacology·2025
Same author

Exposure-Efficacy Meta-Model of Nintedanib in Adult Patients With Chronic Fibrosing Interstitial Lung Diseases.

CPT: pharmacometrics & systems pharmacology·2025
Same author

A quantitative systems pharmacology model to inform clinical translation of dynamic PKPD relationships of engineered IL-15.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2025
Same author

Correction: Cellular Kinetics and Biodistribution of Adoptive T Cell Therapies: from Biological Principles to Effects on Patient Outcomes.

The AAPS journal·2025
Same author

A Pharmacometric Workflow for Resolving Model Instability in Model Use-Reuse Settings.

CPT: pharmacometrics & systems pharmacology·2025
Same journal

Cohort population analysis of sparse data: Dexamethasone pharmacokinetics in mother and fetus based on blood sampling at birth.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Bridging the operational gap in population pharmacokinetic-pharmacodynamic analysis: an international perspective on the 2025 Chinese group standard.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Advancing quantitative clinical pharmacology competencies in Francophone Africa through an on-line learning framework.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Optimizing Subcutaneous Antibody Dosing Regimens Through Operating Space Maps: rHuPH20 Case Study.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Mechanistic modeling of FcRn-dependent IgG drug interactions: Clinical applications and dosing implications.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Comparing heavy-tailed residual error models for outlier handling in population PK modeling.

Journal of pharmacokinetics and pharmacodynamics·2026
See all related articles

Related Experiment Video

Updated: May 4, 2026

Experimental Methods to Study Human Postural Control
08:12

Experimental Methods to Study Human Postural Control

Published on: September 11, 2019

9.1K

Parameterisation affects identifiability of population models.

Vittal Shivva1, Julia Korell, Ian G Tucker

  • 1School of Pharmacy, University of Otago, P.O. Box 56, Dunedin, 9054, New Zealand, vittal.shivva@otago.ac.nz.

Journal of Pharmacokinetics and Pharmacodynamics
|January 1, 2014
PubMed
Summary
This summary is machine-generated.

Model identifiability is crucial. This study demonstrates how fixed effects parameterization impacts the identifiability of random effects variances in pharmacokinetic models.

More Related Videos

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

2.9K
Predicting the Effectiveness of Population Replacement Strategy Using Mathematical Modeling
20:36

Predicting the Effectiveness of Population Replacement Strategy Using Mathematical Modeling

Published on: July 4, 2007

8.2K

Related Experiment Videos

Last Updated: May 4, 2026

Experimental Methods to Study Human Postural Control
08:12

Experimental Methods to Study Human Postural Control

Published on: September 11, 2019

9.1K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

2.9K
Predicting the Effectiveness of Population Replacement Strategy Using Mathematical Modeling
20:36

Predicting the Effectiveness of Population Replacement Strategy Using Mathematical Modeling

Published on: July 4, 2007

8.2K

Area of Science:

  • Pharmacometrics
  • Mathematical Modeling
  • Systems Biology

Background:

  • Model identifiability is a critical consideration in the development and validation of pharmacokinetic models.
  • Ensuring that model parameters can be uniquely estimated from observed data is essential for reliable predictions.
  • Population pharmacokinetic (PopPK) models incorporate inter-individual variability, introducing additional complexity to identifiability assessments.

Purpose of the Study:

  • To investigate the influence of fixed effects parameterization on the identifiability of random effects variances.
  • To elucidate the relationship between different parameterization strategies and the estimability of inter-individual variability in a simple pharmacokinetic model.
  • To provide insights into best practices for PopPK model development regarding parameterization choices.

Main Methods:

  • Utilized a simple one-compartment population pharmacokinetic model structure.
  • Systematically varied the parameterization of fixed effects.
  • Assessed the identifiability of random effects variances under different parameterization scenarios.

Main Results:

  • Demonstrated that the parameterization of fixed effects significantly impacts the identifiability of random effects variances.
  • Identified specific fixed effects parameterization choices that lead to poor identifiability of variance parameters.
  • Showcased how seemingly equivalent parameterizations can have different identifiability properties.

Conclusions:

  • The choice of fixed effects parameterization is not arbitrary and has direct consequences for PopPK model identifiability.
  • Careful consideration of parameterization is necessary to ensure reliable estimation of inter-individual variability.
  • This finding has implications for model building, diagnostics, and the interpretation of results in population pharmacokinetic analyses.